Published in Surgery Litigation and Law Weekly, March 2nd, 2007
The company issued 10,000,000 shares of common stock at $0.25 per share and warrants to purchase an aggregate of 10,000,000 shares of common stock at an exercise price of $0.32 per share. The net proceeds of the sale of the common stock and the warrants are to be used for working capital and general corporate purposes which include capital for growth of its new medical market initiatives, as well as supporting working capital needs for ongoing product development and the company's recently announced receipt of initial production orders for an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.